Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Juan Miguel Mosquera
Affiliation
Caryl and Israel Englander Institute for Precision Medicine
ORCID
Career Start Year
2002
Papers
134
H Index
54
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38047392
NIPBL::NACC1 Fusion Hepatic Carcinoma.
Am J Surg Pathol
2024
37652664
The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.
Cold Spring Harb Mol Case Stud
2024
38047392
NIPBL::NACC1 Fusion Hepatic Carcinoma.
Am J Surg Pathol
2024
37652664
The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer.
Cold Spring Harb Mol Case Stud
2024
35968961
GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.
Am J Surg Pathol
2023
35968961
GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.
Am J Surg Pathol
2023
37587346
Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers.
Nature
2023
37919447
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.
NPJ Precis Oncol
2023
37704749
Evolution of structural rearrangements in prostate cancer intracranial metastases.
NPJ Precis Oncol
2023
37489101
Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.
Am J Surg Pathol
2023
37223924
Immunogenomic Landscape of Neuroendocrine Prostate Cancer.
Clin Cancer Res
2023
37919447
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.
NPJ Precis Oncol
2023
37489101
Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.
Am J Surg Pathol
2023
37704749
Evolution of structural rearrangements in prostate cancer intracranial metastases.
NPJ Precis Oncol
2023
37587346
Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers.
Nature
2023
37223924
Immunogenomic Landscape of Neuroendocrine Prostate Cancer.
Clin Cancer Res
2023
34676924
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.
Adv Mater
2022
35510953
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.
J Exp Med
2022
35644123
Weakly-supervised tumor purity prediction from frozen H&E stained slides.
EBioMedicine
2022
35637420
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing.
Nat Biotechnol
2022
35490048
A multidisciplinary approach to optimize primary prostate cancer biobanking.
Urol Oncol
2022
35617398
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.
Science
2022
35483877
Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
Cold Spring Harb Mol Case Stud
2022
36414761
Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging.
Nat Methods
2022
36387205
Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment.
Front Oncol
2022
36316562
Unsupervised discovery of tissue architecture in multiplexed imaging.
Nat Methods
2022
36577525
Whole-genome characterization of myoepithelial carcinomas of the soft tissue.
Cold Spring Harb Mol Case Stud
2022
35046520
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer
2022
34676924
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.
Adv Mater
2022
35231161
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.
Mol Oncol
2022
35230579
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.
Ann Surg Oncol
2022
34773394
Fine-needle aspiration biopsy of growing teratoma syndrome as a diagnostic pitfall of metastatic adenocarcinoma.
Diagn Cytopathol
2022
34483300
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.
Int J Gynecol Pathol
2022
35220606
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.
J Pathol
2022
35050902
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
JCI Insight
2022
35617398
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.
Science
2022
35510953
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.
J Exp Med
2022
35644123
Weakly-supervised tumor purity prediction from frozen H&E stained slides.
EBioMedicine
2022
35637420
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing.
Nat Biotechnol
2022
35490048
A multidisciplinary approach to optimize primary prostate cancer biobanking.
Urol Oncol
2022
35483877
Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
Cold Spring Harb Mol Case Stud
2022
36577525
Whole-genome characterization of myoepithelial carcinomas of the soft tissue.
Cold Spring Harb Mol Case Stud
2022
36414761
Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging.
Nat Methods
2022
36387205
Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment.
Front Oncol
2022
36316562
Unsupervised discovery of tissue architecture in multiplexed imaging.
Nat Methods
2022
35046520
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer
2022
35220606
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.
J Pathol
2022
35050902
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
JCI Insight
2022
35231161
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.
Mol Oncol
2022
35230579
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype.
Ann Surg Oncol
2022
1 - 50 of 268
Column Actions
Search
Recommended Authors
David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year
2018
Number of shared co-authors
13
Job van Riet
Erasmus MC Cancer Institute
Career Start Year
2017
Number of shared co-authors
2
Wei Yuan
The Institute for Cancer Research
Career Start Year
2015
Number of shared co-authors
37
Amy Lum
University of British Columbia
Career Start Year
2014
Number of shared co-authors
2
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year
2011
Number of shared co-authors
5
Matti Annala
University of British Columbia
Career Start Year
2011
Number of shared co-authors
25
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
24
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
27
Katayoon Kasaian
Ontario Institute for Cancer Research
Career Start Year
2008
Number of shared co-authors
21
Somak Roy
University of Cincinnati College of Medicine
Career Start Year
2007
Number of shared co-authors
13
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year
2006
Number of shared co-authors
3
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year
2006
Number of shared co-authors
58
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year
2005
Number of shared co-authors
44
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
10
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
13
Sherri Z Millis
Foundation Medicine Inc
Career Start Year
2003
Number of shared co-authors
4
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year
2003
Number of shared co-authors
3
Maryou B Lambros
The Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
34
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2001
Number of shared co-authors
2
Ga??lle Pierron
Institut Curie Hospital
Career Start Year
2001
Number of shared co-authors
3
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
12
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
13
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year
1997
Number of shared co-authors
0
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
19
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year
1996
Number of shared co-authors
9
Siraj M Ali
Foundation Medicine
Career Start Year
1995
Number of shared co-authors
16
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year
1993
Number of shared co-authors
7
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year
1990
Number of shared co-authors
14
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year
1984
Number of shared co-authors
57
row(s) 1 - 30 of 30
Collaborators
Mark A Rubin
University of Bern
Co-authored papers
74
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers
53
Olivier Elemento
Meyer Cancer Center
Co-authored papers
50
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers
49
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers
32
Francesca Demichelis
University of Trento
Co-authored papers
30
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers
23
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers
23
Kyung Park
New York University Langone Health
Co-authored papers
22
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers
22
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers
19
Kenneth Eng
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers
18
Rohan Bareja
Case Western Reserve University
Co-authored papers
18
Christopher E Barbieri
Weill Cornell Medical College
Co-authored papers
17
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Co-authored papers
14
Davide Prandi
University of Trento
Co-authored papers
12
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers
12
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers
12
David Wilkes
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers
12
Rema Rao
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers
11
Loredana Puca
Sandra and Edward Meyer Cancer Center
Co-authored papers
10
Ana M Molina
Englander Institute for Precision Medicine
Co-authored papers
10
Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Co-authored papers
10
Chantal Pauli
University Hospital Zurich
Co-authored papers
10
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers
9
Alessandro Romanel
University of Trento
Co-authored papers
9
Alexandros Sigaras
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers
9
Cora N Sternberg
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers
9
Shaham Beg
New York-Presbyterian Hospital-Weill Cornell Medical College
Co-authored papers
9
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers
9
1 - 30